tetano
Editor, Senior Moderator
Heliyon
. 2023 Aug 25;9(9):e19490.
doi: 10.1016/j.heliyon.2023.e19490. eCollection 2023 Sep. Characteristics and in-hospital mortality of patients with COVID-19 from the first to fifth waves of the pandemic in 2020 and 2021 in the Japanese Medical Data Vision database
Toshiki Suzuki[SUP] 1 [/SUP], Yuta Taniguchi[SUP] 2 3 [/SUP], Jun Komiyama[SUP] 2 4 [/SUP], Toshiki Kuno[SUP] 5 [/SUP], Motohiko Adomi[SUP] 2 6 [/SUP], Toshikazu Abe[SUP] 3 7 [/SUP], Ryota Inokuchi[SUP] 4 [/SUP], Atsushi Miyawaki[SUP] 3 8 [/SUP], Shinobu Imai[SUP] 9 [/SUP], Makoto Saito[SUP] 10 [/SUP], Hiroyuki Ohbe[SUP] 11 [/SUP], Shotaro Aso[SUP] 12 [/SUP], Tadashi Kamio[SUP] 13 [/SUP], Nanako Tamiya[SUP] 3 4 [/SUP], Masao Iwagami[SUP] 3 4 14 [/SUP]
Affiliations
Objectives: We aimed to describe patient characteristics, healthcare utilization, and in-hospital mortality among patients with COVID-19 in Japan across waves.
Methods: Using a large-scale hospital-based database, we identified patients hospitalized for COVID-19 in the first (January-June 2020), second (June-October 2020), third (October 2020-February 2021), fourth (March-June 2021), and fifth (June-December 2021) waves. We summarized patient characteristics, healthcare utilization, and in-hospital mortality during each wave and performed multivariable logistic regression analyses for in-hospital mortality.
Results: From the first to fifth waves, the number of patients (mean age ± standard deviation, years) was 2958 (61.2 ± 22.8), 7981 (55.6 ± 25.3), 18,788 (63.6 ± 22.9), 17,729 (60.6 ± 22.6), and 23,656 (51.2 ± 22.3), respectively. There were 190 (6.4%), 363 (4.5%), 1261 (6.7%), 1081 (6.1%), and 762 (3.2%) in-hospital deaths, respectively. The adjusted odds ratios for in-hospital deaths (95% confidence interval) were 0.78 (0.65-0.95), 0.94 (0.79-1.12), 0.99 (0.84-1.18), 0.77 (0.65-0.92), in the second to fifth waves, respectively, compared with the first wave.
Conclusions: In-hospital COVID-19 mortality improved from the first to the second wave; however, during the third and fourth waves, mortality was as serious as in the first wave. Although in-hospital mortality during the fifth wave improved, careful monitoring is needed for upcoming waves, considering changing patient and viral characteristics.
Keywords: Dexamethasone; Electronic health records; Epidemiology; Severe acute respiratory syndrome coronavirus 2.
. 2023 Aug 25;9(9):e19490.
doi: 10.1016/j.heliyon.2023.e19490. eCollection 2023 Sep. Characteristics and in-hospital mortality of patients with COVID-19 from the first to fifth waves of the pandemic in 2020 and 2021 in the Japanese Medical Data Vision database
Toshiki Suzuki[SUP] 1 [/SUP], Yuta Taniguchi[SUP] 2 3 [/SUP], Jun Komiyama[SUP] 2 4 [/SUP], Toshiki Kuno[SUP] 5 [/SUP], Motohiko Adomi[SUP] 2 6 [/SUP], Toshikazu Abe[SUP] 3 7 [/SUP], Ryota Inokuchi[SUP] 4 [/SUP], Atsushi Miyawaki[SUP] 3 8 [/SUP], Shinobu Imai[SUP] 9 [/SUP], Makoto Saito[SUP] 10 [/SUP], Hiroyuki Ohbe[SUP] 11 [/SUP], Shotaro Aso[SUP] 12 [/SUP], Tadashi Kamio[SUP] 13 [/SUP], Nanako Tamiya[SUP] 3 4 [/SUP], Masao Iwagami[SUP] 3 4 14 [/SUP]
Affiliations
- PMID: 37809807
- PMCID: PMC10558584
- DOI: 10.1016/j.heliyon.2023.e19490
Objectives: We aimed to describe patient characteristics, healthcare utilization, and in-hospital mortality among patients with COVID-19 in Japan across waves.
Methods: Using a large-scale hospital-based database, we identified patients hospitalized for COVID-19 in the first (January-June 2020), second (June-October 2020), third (October 2020-February 2021), fourth (March-June 2021), and fifth (June-December 2021) waves. We summarized patient characteristics, healthcare utilization, and in-hospital mortality during each wave and performed multivariable logistic regression analyses for in-hospital mortality.
Results: From the first to fifth waves, the number of patients (mean age ± standard deviation, years) was 2958 (61.2 ± 22.8), 7981 (55.6 ± 25.3), 18,788 (63.6 ± 22.9), 17,729 (60.6 ± 22.6), and 23,656 (51.2 ± 22.3), respectively. There were 190 (6.4%), 363 (4.5%), 1261 (6.7%), 1081 (6.1%), and 762 (3.2%) in-hospital deaths, respectively. The adjusted odds ratios for in-hospital deaths (95% confidence interval) were 0.78 (0.65-0.95), 0.94 (0.79-1.12), 0.99 (0.84-1.18), 0.77 (0.65-0.92), in the second to fifth waves, respectively, compared with the first wave.
Conclusions: In-hospital COVID-19 mortality improved from the first to the second wave; however, during the third and fourth waves, mortality was as serious as in the first wave. Although in-hospital mortality during the fifth wave improved, careful monitoring is needed for upcoming waves, considering changing patient and viral characteristics.
Keywords: Dexamethasone; Electronic health records; Epidemiology; Severe acute respiratory syndrome coronavirus 2.